Audited by PwC

Balance sheet - the Novozymes Group

Print
Note Dec. 31, 2011   Dec. 31, 2010
      DKK million DKK million  
ASSETS
11 Intangible assets 2,221  1,070 
13 Property, plant and equipment 6,557  5,866 
14 Deferred tax assets 275  71 
15 Other financial assets     - 50   
Non-current assets, total 9,053  7,057 
16 Inventories 1,741  1,640 
17 Trade receivables 1,971  1,772 
18 Tax receivables 167  232 
19 Other receivables 195  249 
15 Other financial assets 48  178 
Cash at bank and in hand   667  1,465   
Current assets, total 4,789  5,536 
Assets, total   13,842  12,593   
           
LIABILITIES AND SHAREHOLDERS' EQUITY
20 Common stock 650  650 
20 Treasury stock (1,714) (1,479)
Other reserves 465  540 
Retained earnings 9,408  8,113 
21 Minority interests   15  12   
Shareholders' equity, total 8,824  7,836 
14 Deferred tax liabilities 905  493 
22 Provisions 152  182 
23 Other financial liabilities   1,604  1,574   
Non-current liabilities, total 2,661  2,249 
23 Other financial liabilities 258  291 
22 Provisions 98  50 
Trade payables 745  764 
18 Tax payables 37  86 
24 Other payables   1,219  1,317   
Current liabilities, total 2,357  2,508 
         
Liabilities, total 5,018  4,757 
Liabilities and shareholders' equity, total 13,842  12,593